v3.26.1
Condensed Statement of Changes in Shareholders' Deficit - 3 months ended Mar. 31, 2026 - USD ($)
Total
Ordinary Shares [Member]
Class A [Member]
Ordinary Shares [Member]
Class B [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Beginning balance (in shares) at Dec. 31, 2025 [1]   0 8,852,917    
Beginning balance at Dec. 31, 2025 [1] $ (27,950) $ 0 $ 885 $ 24,115 $ (52,950)
Sale of 672,000 Private Placement Units (In Shares)   672,000      
Sale of 672,000 Private Placement Units 6,720,000 $ 67   6,719,933  
Fair Value of Public Warrants at issuance 3,802,050     3,802,050  
Allocated value of transaction costs to Class A shares (254,374)     (254,374)  
Capital contribution made by Sponsor related to the interests in founders shares allocated to non-managing members 3,513,866     3,513,866  
Cost of raising capital related to interests in founders shares allocated to non-managing members (3,513,866)     (3,513,866)  
Forfeiture of Founder Shares     (345,083)    
Forfeiture of Founder Shares, Value     $ (34) 34  
Share-based compensation 82,535     82,535  
Accretion for Class A ordinary shares to redemption amount (19,891,310)     (10,374,293) (9,517,017)
Net Income (Loss) 423,410       423,410
Ending balance (in shares) at Mar. 31, 2026   672,000 8,507,834    
Ending balance at Mar. 31, 2026 $ (9,145,639) $ 67 $ 851 $ 0 $ (9,146,557)
[1] Included an aggregate of up to 1,136,250 Class B ordinary shares subject to forfeiture by the holders thereof depending on the extent to which the underwriters’ over-allotment option was exercised (see Note 4). On February 19, 2026, the Underwriters partially exercised its over-allotment option and forfeited the unexercised balance. As a result of the partial exercise and the forfeiture of the over-allotment option by the Underwriters, 791,167 of such founder shares are no longer subject to forfeiture and 345,083 of such founder shares were forfeited.